Summary
Ecolab Inc. (ECL) reported strong top-line performance in its 2022 10-K filing, with reported sales increasing by 11% to $14.2 billion, driven by double-digit growth across most segments. This growth was fueled by significant pricing actions that effectively offset substantial increases in delivered product costs. While operating income remained stable, it was impacted by higher costs and strategic investments. The company's financial position remains robust, supported by an "A" range credit rating and strong cash flow generation, enabling continued investment in the business and shareholder returns through dividends and share repurchases. Despite economic headwinds, including inflation and geopolitical instability, Ecolab maintained its commitment to sustainability and innovation, aligning its business strategy with long-term global challenges. The acquisition of Purolite in December 2021 for $3.7 billion has been integrated and is contributing to the Life Sciences segment. The company is also executing on various restructuring plans aimed at enhancing efficiency and streamlining operations, with significant savings anticipated in the coming years. Ecolab's focus on providing water, hygiene, and infection prevention solutions positions it well to capitalize on increasing demand for sustainability and health-focused offerings.
Financial Highlights
55 data points| Revenue | $14.19B |
| Cost of Revenue | $8.83B |
| Gross Profit | $5.36B |
| R&D Expenses | $190.00M |
| SG&A Expenses | $3.65B |
| Operating Income | $1.56B |
| Interest Expense | $252.10M |
| Net Income | $1.09B |
| EPS (Basic) | $3.83 |
| EPS (Diluted) | $3.81 |
| Shares Outstanding (Basic) | 285.20M |
| Shares Outstanding (Diluted) | 286.60M |
Key Highlights
- 1Reported sales increased 11% to $14.2 billion in 2022, driven by strong pricing and volume growth across key segments.
- 2Gross margin decreased slightly to 37.8% from 40.2% in the prior year, primarily due to higher delivered product costs outweighing pricing increases.
- 3Operating income remained stable at $1.6 billion, with adjusted operating income seeing a 1% decrease due to product cost inflation and business investments.
- 4Diluted EPS from continuing operations decreased 3% to $3.81, with adjusted diluted EPS down 4% to $4.49, reflecting unfavorable foreign currency translation and increased interest expense.
- 5Cash flow from operating activities was $1.8 billion, a decrease from $2.1 billion in 2021, impacted by increased working capital.
- 6The company maintained a strong balance sheet with total debt of $8.6 billion and recommitted to 'A' range credit rating metrics.
- 7Ecolab continued its commitment to returning capital to shareholders, increasing its quarterly dividend by 4% and marking its 31st consecutive annual dividend rate increase.